A Detailed Analysis: Liposomes Innovative Role as a Drug Delivery System

Year : 2024 | Volume :11 | Issue : 02 | Page : 25-33
By

Satbir Singh

Kehar Singh

Hemant Rana

Jaikaushik

Yakshita Saini

  1. Associate Professor Department of Pharmaceutics, Pt. LR College of Pharmacy, Faridabad Haryana India
  2. Associate Professor Department of Pharmaceutics, Pt. LR College of Pharmacy, Faridabad Haryana India
  3. Assistant Professor Department of Pharmaceutics, Pt. LR College of Pharmacy, Faridabad Haryana India
  4. Under Graduate Pt. LR College of Pharmacy, Faridabad Haryana India
  5. Under Graduate Pt. LR College of Pharmacy, Faridabad Haryana India

Abstract

The first nanomedicine to be approved for use in clinical settings was liposomes. These are the spherical vesicles with a bilayer of phospholipids enclosing a middle empty aqueous region. Because of their extraordinary potential to stop medication deterioration and lessen unwanted effects, liposomes are being utilized more and more for targeted drug distribution. For targeted drug delivery, the pharmaceuticals can be integrated into the liposomes’ aqueous space or phospholipid bilayer. In order to target a medication or substance to the active site at a predetermined rate and time range without impacting other body parts in the process, liposomes are available in a range of sizes to treat different sorts of diseases. Vesicular systems, as they are often called, are colloidal spheres composed of cholesterol, sphingolipids, glycolipids, long-chain unsaturated fats, layer proteins, and active atoms. They are also constituted of non-poisonous surfactants. Liposomes are one of the most often utilized methods in biological, pharmaceutical, medical, and nutritional research for the encapsulation and transport of a wide range of different compounds, including bioactive substances., benefits and drawbacks, as well as different approaches to preparation, assessment etc.. This paper examines the liposomal vesicles’ classification, manufacturing and encapsulating techniques, and uses in the food, cosmetics, and pharmaceutical industries. Furthermore, this section presents the primary analytical techniques utilized to investigate the properties of liposomes, including their size, stability, fluidity, lamellarity, surface charge, and encapsulation efficiency.

Keywords: Liposome, Evaluation, Drug delivery system, Vesicles, MLV, SUV.

[This article belongs to Trends in Drug Delivery(tdd)]

How to cite this article: Satbir Singh, Kehar Singh, Hemant Rana, Jaikaushik, Yakshita Saini. A Detailed Analysis: Liposomes Innovative Role as a Drug Delivery System. Trends in Drug Delivery. 2024; 11(02):25-33.
How to cite this URL: Satbir Singh, Kehar Singh, Hemant Rana, Jaikaushik, Yakshita Saini. A Detailed Analysis: Liposomes Innovative Role as a Drug Delivery System. Trends in Drug Delivery. 2024; 11(02):25-33. Available from: https://journals.stmjournals.com/tdd/article=2024/view=147278

Browse Figures

References

  1. Mehran A, Naser K and Mohsen S: Application of Various Types of Liposomes in Drug Delivery Systems. Adv Pharm Bull 2017; 7(1): 3–9.
  2. Ravichandiran V, Masilamani K and Senthilnathan B: Liposome- A Versatile Drug Delivery System. Der Pharmacia Sinica 2011; 2(1): 19-30
  3. Liu X, Wang J, Miao L, Zhang X, Huang G. Prolonged systemic delivery of antibacterial agent levofloxacin using liposomes. Asian Journal of Pharmaceutical Sciences. 2011 Dec 1;6(6).
  4. Bulbake, U. Doppalaudi, S. Kommineni, N.Khan, W. Liposomal Formulations in Clinical Use: An Updated Review. Pharmaceutics, 2017; 27;9(2):12.
  5. Aditi G, Sharma A, Pandit D and Mahajan SC: a review as liposomal drug delivery and its application world journal of pharmaceutical research2019:8(11):1377-85.
  6. Tripathi PK, Srivastava S. liposome novel drug delivery system. Pharma tutor pharmacy infopedia. Available from: https://www.pharmatutor. Org/ articles/liposomes-novel-drug –delivery- system.
  7. Divyasree R, Divya K, Vamsidhar M, Bhanja SB, Sudhakar M and Panigrahi BB: A comprehensive review on liposomes: a novel drug delivery system . Int J Pharma Sci &Res 2022;13(2):628-44. doi:10.13040/IJPSR.0975-8232.13(2).628-44.
  8. Mishra H, Chauhan V, Kumar K, Teotia D, A comprehensive review on Liposomes: a novel drug delivery system, Journal of Drug delivery andTherapeutics.2018;8(6):400404DOI:http://dx.doi.org/10.22270/jddt.v8i6.2071.
  9. Vyas S.P. and Khar R.K., “Targeted and controlled drug delivery, novel carrier system. 1st edition, BS publishers & distributors; 2004, 173-206.
  10. Feghhi, M. Makhmalzadeh, B.S. Farrahi, F. Akmali, M. Hasanvand, N. Anti-microbial effect and in vivo Ocular Delivery of Ciprofloxacin-loaded Liposome through Rabbit’s Eye. Current Eye Research, 2020;45(10). 1245-51.
  11. Yewale C, Baradia D, Patil S,Amrutiya J, Gandhi R, et al. Docetaxel loaded immunonanoparticles delivery in EGFRoverexpressed carcinoma cells. Journal of Drug Delivery Science and Technology ,2018;45:334-45.
  12. Woodle, M.C.(1995).Sterically stabilized liposome therapeutics. Advanced Drug Delivery Reviews 16(2-3),249-265.
  13. Kaur D and Kumar S: Nisomes: present scenario and future aspects. Journal of Drug Delivery and Therapeutics 2018; 8(5):35-37.
  14. Sen R, Sahoo SK, SatpathyS .liposomess as a drug delivery system : a brief review. From International journal of research in pharmaceutical sciences. Available from: https://en.wikibooks.org/wikihttps://pharmascope.org/php/ijrps/article/download/658/625/Structural_Biochemistry / liposomes.
  15. Vishvakrama, P and Sharma S: Liposomes: an overview. Journal of Drug Delivery and Thereutics 2014; 12: 47-55.
  16. Sanarova E, Lantsova A, Oborotova N and Orlova O: Liposome Drug Delivery, Journal of Pharmaceutical Sciences & Res 2019; 11(3): 1148-55
  17. Utsugil T., Nii A., Fan D.,Pak C.C., Denkins Y., Hoogevest P.V., Fidler I.J. Comparative efficacy of liposomes containing synthetic bacterial cell wall analogues for tumolrcidial activation of monocytes and macrophages. Cancer Immunol. Immunother. 1991;33:285-292. Doi:10.1007/BF01756592
  18. Maierhofer G. (June 1985). Am. Clinical Products. 33. 17.
  19. Mayhew E., Nikolopoulos G.T., King J.J. and Siciliano A.A. (1985). Pharm. Manufacturing.2: 18
  20. Perkin W.,Malinin V., Li X., Miller B., Seidel D., Holzmann P., Schulz H., Hahn M. System for Treating Pulmonary Infections. 9,566,234 B2. U.S. Patent. 2017 February 14
  21. Shailesh S. Neelam S, Sandeep K and Gupta GD: Liposomes: A review , Journal of Pharmacy Research  2009; 2(7): 1163-67.
  22. Rajan K and Sanjay G: Current status of drug delivery technologies and future directions, Journal of Pharmaceutical Technology 2015;25(2): 1-14.
  23. Deshmukh RR, Gawale SV, Bhagawat MK, Ahire PA, Derle ND, A Review on: liposomes, World journal of pharmacy and pharmaceutical sciences, Issue 03, 506 -517.
  24. Claudia Zylberberg and Sandro Matosevic (2016) Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape, Drug Delivery , 23:9, 3319-3329 , DOI: 10.1080/10717544.2016.1177136
  25. Pattni B.S., Chupin V.V., Torchilin V.P. New Developments in liposomes Drug Delivery . Chem Rev. 2015; 115:10938-10966. Doi:10.1021/acs.chemrev.5b00046.
  26. Dwivedi C, Yadav R, Tiwari SP, Satapathy T, Roy A, Role of liposomes in novel drug delivery system , Journal of drug delivery and therapeutics 2014;4(2):116-129.
Regular Issue Subscription Review Article
Volume 11
Issue 02
Received May 3, 2024
Accepted May 13, 2024
Published May 22, 2024
Views: 59